这 Abolition of Mandatory Death Penalty Act 2023 (Act 846) and the Revision of Sentence of Death and Imprisonment for Natural Life (Temporary Jurisdiction of The Federal Court) Act 2023 (Act 847) came into force on 4 July 2023 and 12 September 2023 respectively. Three years on, the practical effects of these reforms — particularly in cases of drug trafficking under Section 39B of the Dangerous Drugs Act 1952 — have become clearer through a steady stream of resentencing applications before the Federal Court.
What Changed
Before Act 846, a conviction for drug trafficking under Section 39B carried a mandatory death sentence. The trial judge had no discretion. Act 846 retains death as an available punishment, but it is now discretionary — the court may impose either (i) death, or (ii) imprisonment of between 30 and 40 years together with whipping of not less than 12 strokes. Mandatory life and “natural life” imprisonment were similarly abolished and replaced with the same 30-to-40-year range.
For prisoners already convicted under the old mandatory regime, Act 847 conferred special temporary jurisdiction on the Federal Court to hear applications for sentence revision. As at January 2025, the number of inmates on death row for drug offences had reduced to approximately 40, down from several hundred before the reform — a direct reflection of successful resentencing applications.
Sentencing Principles Emerging from Recent Decisions
The Federal Court’s resentencing exercise has been guided by familiar mitigating and aggravating factors: (a) the quantity and type of drugs involved; (b) the role of the offender in the trafficking chain (courier versus principal); (c) personal circumstances including age, dependants, and conduct in prison since conviction; (d) plea and cooperation with authorities; and (e) any disability, illness, or evidence of duress or coercion.
These factors are no longer relevant only to mitigation pleas during sentencing — they are now the basis on which the court selects between death and the 30-to-40-year alternative.
Practical Implications
If you or a family member is facing a Section 39B charge, the most important shift is that sentencing now turns on evidence — not on the operation of a mandatory statute. Mitigation evidence, character references, and a properly prepared sentencing case can change the outcome. For those already serving the old mandatory sentence, the Act 847 resentencing window remains open, and a carefully prepared application supported by fresh evidence of rehabilitation or factual matters not put before the original sentencing court can succeed.
If you are seeking advice on a drug trafficking charge or a resentencing application, please contact Chris & Partners for a paid consultation.
中文版本
从强制性到酌情性: 马来西亚死刑改革三周年 — 对贩毒被告的实际意义
《2023年废除强制死刑法令》(法令第846号) 与《死刑及终身监禁刑罚检讨 (联邦法院临时管辖权) 法令 2023》(法令第847号) 分别于2023年7月4日及9月12日生效。改革实施三年后，对1952年《危险毒品法令》第39B条贩毒罪行的实际影响已通过联邦法院持续审理的复审申请逐渐明朗。
改革要点
在第846号法令生效前，根据第39B条被裁定贩毒罪成的被告将被判处强制死刑，审讯法官并无自由裁量权。第846号法令保留死刑作为可选刑罚，但已改为酌情性 — 法院可判处 (一) 死刑，或 (二) 30至40年监禁，连同至少12下鞭刑。强制终身监禁及”自然终身”监禁亦被同样废除，并以30至40年的刑期范围取代。
对于在旧强制制度下已被定罪的囚犯，第847号法令授予联邦法院特别临时管辖权，可审理减刑申请。截至2025年1月，因毒品罪行而被关押在死囚牢房的人数减至约40人 — 这是减刑申请成功的直接反映。
最新判例显示的量刑原则
联邦法院的复审工作遵循一系列减轻及加重情节因素：(甲) 涉及毒品的数量及种类；(乙) 被告在贩毒链中的角色 (信使 vs 主犯)；(丙) 个人情况，包括年龄、家庭依赖、定罪后的狱中表现；(丁) 认罪态度及对当局的合作；(戊) 残疾、疾病或受胁迫的证据。这些因素不再仅是量刑减轻的考量 — 它们如今是法院在死刑与30至40年监禁之间作出选择的依据。
实际意义
如您或家人面对第39B条的指控，最重大的转变是：量刑现在取决于证据 — 而非强制性法规的运作。减轻情节证据、人格证人陈述及妥善准备的量刑陈词，皆可改变审判结果。对于在旧强制制度下服刑者，第847号法令所开放的复审申请窗口仍然有效，凡有更生迹象或原审庭未曾考虑的事实证据，皆有可能获得减刑。
如您正面对贩毒指控或考虑提交复审申请，欢迎联系Chris & Partners预约付费咨询。